期刊文献+

对应分析在慢性肾脏病患者住院费用影响因素中的应用 被引量:2

Application of Correspondence Analysis on the Chronic Kidney Disease Hospitalization Cost and Its Influence Factors
原文传递
导出
摘要 目的探讨慢性肾脏病住院费用及其与各因素之间的对应关系。方法通过医院信息管理系统收集某三甲医院2015年1月至12月的慢性肾脏病患者病案首页及出院后费用资料,采用SPSS16.0对数据进行统计分析,描述慢性肾脏病患者住院费用及其构成情况,通过对应分析探讨费用与各因素之间的对应关系。结果 242例慢性肾脏病的平均住院费用为8561.69(7065.35-10,888.99),药费和检查化验费分别占总费用的46.56%和30.72%,对应分析结果发现,CKD-2期、青年、住院时间短且支付方式为城镇职工医疗保险的患者对应的总费用最低,CKD-5期、老年、住院时间长且支付方式为全自费的患者对应的总费用最高。结论慢性肾脏病患者住院费用很高,年龄、CKD分期、住院时间及费用支付方式是慢性肾脏病费用高的重要因素。 Objective To explore the correspondence association of chronic kidney disease hospitalization cost with its influence factors. Methods The relevant information about hospitalization expenses of chronic kidney disease was collected from the information management system of a third level hospital from January to December, 2015. Data was conducted by SPSS 16. 0 software. Chronic kidney disease hospitalization cost and its components were described. Correspondence analysis was conducted explore the relationship between hospitalization cost and its influence factors. Results The median hospital cost of chronic kidney disease was RMB 8561.69 (25%-75%:7065.35-10, 888.99). 46. 56% and 30. 72% of the total costs were made up of drugs and laboratory examination fee. In correspondence analysis, patients of CKD-2, the young, those who were in hospital with a short time and had an urban worker medical insurance correspondent to the lowest hospital cost. In contrast, patients of CKD-5, the old, those who were in hospital with a long time and had no medical insurance correspondent to the highest hospital cost. Conclusion The hospital cost of chronic kidney disease was expensive. Age, the stage of CKD, hospitalization time and medical insurance were associated with cost in survival chronic kidney disease patients.
出处 《中国病案》 2017年第2期59-62,共4页 Chinese Medical Record
关键词 慢性肾脏病 住院费用 影响因素 对应分析 Chronic kidney disease Hospitalization cost Influence factors Correspondence analysis
  • 相关文献

参考文献5

二级参考文献73

  • 1杨小兵,侯凡凡,武强,周华,刘郑荣,杨燕,张训.慢性肾脏病患者晚期氧化蛋白产物血症及其与动脉粥样硬化的关系[J].中华内科杂志,2005,44(5):342-346. 被引量:41
  • 2<活性维生素D的合理应用>专家协作组.活性维生素D在慢性肾脏病继发性甲旁亢中合理应用的专家共识(修订版)[J].中华肾脏病杂志,2005,21(11):698-699. 被引量:97
  • 3徐国宾,李志艳.应重视实验室检查在慢性肾病早期诊断中的应用[J].中华检验医学杂志,2006,29(11):961-965. 被引量:78
  • 4Liu SX, Hou FF, Guo ZJ, et al. Advanced oxidation protein products accelerate atherosclerosis through promoting oxidative stress and inflammation. Arterioscler Thromb Vasc Biol, 2006, 26: 1156-1162.
  • 5Li HY, Hou FF, Zhang X, et al. Advanced oxidation protein products accelerate renal fibrosis in a remnant kidney model. J Am Soe Nephrol, 2007, 18: 528-538.
  • 6Shi XY, Hou FF, Niu HX, et al. Advanced oxidation protein products promote inflammation in diabetic kidney through activation of renal nicotinamide adenine dinucleotide phosphate oxidase. Endocrinology, 2008, 149: 1829-1839.
  • 7He LJ, Liang M, Hou FF, et al. Ethanol extraction of Picrorhiza scrophulariiflora prevents renal injury in experimental diabetes via anti-inflammation action. J Endocrinol, 2009, 200 : 347-355.
  • 8Guo Z J, Hou FF, Liu SX, et al. Picrorhiza scrophulariiflora improves accelerated athemsclerosis through inhibition of redoxsensitive inflammation. Int J Cardiol, 2009, in press, doi: 10. 1016/j. ijcard. 2008.12. 102.
  • 9Collins A J, Couser WG, Dirks JH, et al. World Kidney Day: an idea whose time has come. Kidney Int, 2006, 69:781-782.
  • 10Li ZY, Xu GB, Xia TA, et al. Prevalence of chronic kidney disease in a middle and old-aged population of Beijing. Clin Chim Acta, 2006, 366: 209-215.

共引文献225

同被引文献24

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部